v3.26.3
Stockholders’ Equity
 9 Months Ended
Sep. 30, 2026
Stockholders’ Equity [Abstract]  
Stockholders’ Equity
(4) Stockholders’ Equity
 
Stock-Based Compensation
 
The Company applies ASC 718, Compensation–Stock Compensation (Topic 718) (“ASC 718”), to account for stock-based compensation.
The table below summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and nine months ended September 30, 2026 and 2025, respectively, as follows:
 
                  
 

3 Months Ended
September 30,
 

9 Months Ended
September 30,
 
    2026      2025     2026     2025  
                          
Data and product costs
  $ 11,898    $ 6,906   $ 33,234   $ 24,993 
Selling, general and administrative expenses
    22,832      15,854     64,113     48,235 
                          
   $ 34,730    $ 22,760   $ 97,347   $ 73,228 
 
Stock Options
 
There were no stock options exercised during the three and nine months ended September 30, 2026.
 
On April 1, 2025, the Company issued 45,100 shares of common stock upon the exercise of stock options. The stock options had a weighted-average exercise price of $2.15 per share. The Company received cash proceeds totaling $96,935 in connection with the exercise of these stock options. The total intrinsic value of the stock options exercised during the three and nine months ended September 30, 2025 was approximately $20,325.